A blood test could help clinicians identify patients with traumatic brain injury (TBI) who may otherwise go undiagnosed.

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.

New research reveals how autoimmune kidney inflammation develops and identifies an antibody-based strategy that may prevent ...

GLP-1 medications may reduce complications after surgery, with new research linking their use to fewer cardiovascular events ...

Eric Easom is the co-founder and CEO of AN2 Therapeutics, a biopharmaceutical company developing small molecule therapies using its boron chemistry platform. Prior to co-founding AN2, Easom was part ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

The U.K. biotech IMU Biosciences will help create a large and detailed immune dataset for 80,000 people in the UK Biobank.

Clinical trials are generating increasingly large amounts of data, but companies are under immense pressure to complete trials quickly and under budget. Could agentic artificial intelligence (AI) be ...

Kiszala, the CEO and co-founder of intoDNA, to explore how a breakthrough in understanding DNA damage and repair could ...